Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris

NCT01320033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

662

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: CD2475/101 40 mg
DRUG: Doxycycline 100 mg
DRUG: Placebo

Sponsor

Galderma R&D